Associations between serum lipoprotein(a) levels and the severities of aortic and coronary atherosclerosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1532-429X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Associations between serum lipoprotein(a) levels and the severities of aortic and coronary atherosclerosis ; volume:12 ; number:1 ; day:21 ; month:1 ; year:2010 ; pages:1-2 ; date:1.2010
Journal of cardiovascular magnetic resonance ; 12, Heft 1 (21.1.2010), 1-2, 1.2010
- Creator
-
Momiyama, Yukihiko
- Contributor
-
Ohmori, Reiko
Fayad, Zahi A.
Kihara, Teruyoshi
Kato, Ryuichi
Taniguchi, Hiroaki
Nagata, Masayoshi
Nakamura, Haruo
Ohsuzu, Fumitaka
SpringerLink (Online service)
- DOI
-
10.1186/1532-429X-12-S1-P131
- URN
-
urn:nbn:de:1111-201603223351
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Momiyama, Yukihiko
- Ohmori, Reiko
- Fayad, Zahi A.
- Kihara, Teruyoshi
- Kato, Ryuichi
- Taniguchi, Hiroaki
- Nagata, Masayoshi
- Nakamura, Haruo
- Ohsuzu, Fumitaka
- SpringerLink (Online service)
Other Objects (12)
Lipoprotein(a)
The relationship between oxidized lipoprotein(a) and carotid atherosclerosis in asymptomatic subjects: A comparison with native lipoprotein(a)
Lipoprotein(a) and its role in inflammation, atherosclerosis and malignancies
Lipoprotein(a) in nephrological patients
Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease
Automated Turbidimetry of Serum Lipoprotein(a)
Therapeutic Potential of Lipoprotein(a) Inhibitors
Lipoprotein(a): from Causality to Treatment
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Serum lipoprotein(a) and 3-year outcomes in patients undergoing percutaneous coronary intervention
Lipoprotein(a) - bedeutsam für die kardiovaskuläre Prävention
Lipoprotein(a)
The relationship between oxidized lipoprotein(a) and carotid atherosclerosis in asymptomatic subjects: A comparison with native lipoprotein(a)
Lipoprotein(a) and its role in inflammation, atherosclerosis and malignancies
Lipoprotein(a) in nephrological patients
Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease
Automated Turbidimetry of Serum Lipoprotein(a)
Therapeutic Potential of Lipoprotein(a) Inhibitors
Lipoprotein(a): from Causality to Treatment
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Serum lipoprotein(a) and 3-year outcomes in patients undergoing percutaneous coronary intervention
Lipoprotein(a) - bedeutsam für die kardiovaskuläre Prävention
Lipoprotein(a)
The relationship between oxidized lipoprotein(a) and carotid atherosclerosis in asymptomatic subjects: A comparison with native lipoprotein(a)
Lipoprotein(a) and its role in inflammation, atherosclerosis and malignancies
Lipoprotein(a) in nephrological patients
Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease
Automated Turbidimetry of Serum Lipoprotein(a)
Therapeutic Potential of Lipoprotein(a) Inhibitors
Lipoprotein(a): from Causality to Treatment
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Serum lipoprotein(a) and 3-year outcomes in patients undergoing percutaneous coronary intervention